About 1,648,588 results (4,173 milliseconds)

NO. 11-5205 ORAL ARGUMENT HAS NOT BEEN SCHEDULED IN ...

https://sites.google.com/site/tedfrank/files/11-5205.cravenopeningasfiled.pdf?attredirects=1
3850) (A784–836); the December 21, 2010 orders granting preliminary approval ... crimination are prime examples' of what (b)(2) is meant to capture ...

US20130144460A1 - Car location - Google Patents

https://patents.google.com/patent/US20130144460A1/en
... PRIME-MOVERS IN VEHICLES; AUXILIARY DRIVES FOR VEHICLES ... 3850 can increase the sampling rate and/or sensitivity of any one or more of ...

WO2017074526A1 - Liver-specific constructs, factor viii expression ...

https://patents.google.com/patent/WO2017074526A1/en
GCCTCTGGCCACATCAGGGACTTCCAGATCACTGCCTCTGGCCAGTATGG - 3850 ... Methods and compositions for prime editing nucleotide sequences. US11453639B2 2019-01-11 2022 ...

WO2022256714A2 - Genome editing compositions and methods for ...

https://patents.google.com/patent/WO2022256714A2/en
... prime editor, and the corresponding prime editing system a PE2 prime editing system. ... 3850, 3866, 3867, 3870, 3872, 3873, 3881, 3886, 3888, 3889, 3890 ...

CN102025304B - Method for reducing vibration and noise of ...

https://patents.google.com/patent/CN102025304B/en
... 3850) think if the common factor of groove/number of poles ... number of magnetic poles and the relatively prime principle of teeth groove number usually.

US5720954A - Monoclonal antibodies directed to the HER2 ...

https://patents.google.com/patent/US5720954A/en
The immunochemical derivatives of the antibodies of this invention that are of prime ... Factor Receptor Cancer Research 47:3847 3850 (1987). *. Urban et al., " ...

KR20140076543A - Circulating biomarkers for cancer - Google ...

https://patents.google.com/patent/KR20140076543A/en
The phenotype can be caused not only by the expression of the subject's genes, but also by the effects of environmental factors and their interactions, as well ...

US20030115463A1 - Requesting Execution of Instructions on ...

https://patents.google.com/patent/US20030115463A1/en
The electronic key 3850 securely protects therein a private key of a public-private key pair. ... Prime, Inc. Systems and methods for implementing an ...

AU2013243947A1 - Modified polynucleotides for the production of ...

https://patents.google.com/patent/AU2013243947A1/en
... 3850 378511 12616 21382,30148, 38914, 47680, 56446 3696 fibrosin-like 1 ... PRIME end of clone 38977, 47743, CSOCAP004YO05 of 56509 Thymus of Homo ...

US5772997A - Monoclonal antibodies directed to the HER2 ...

https://patents.google.com/patent/US5772997A/en
The immunochemical derivatives of the antibodies of this invention that are of prime ... Factor Receptor Cancer Reserch 47:3847 3850 (1987). *. Urban et al., " ...

US7416859B2 - Rhodococcus cloning and expression vectors ...

https://patents.google.com/patent/US7416859B2/en
The term “selectable marker” means an identifying factor, usually an antibiotic or chemical resistance gene, that is able to be selected for based upon the ...

WO2017139576A1 - Vcn enhancer compositions and methods of ...

https://patents.google.com/patent/WO2017139576A1/en
... prime limiting factors preventing HSC-based gene therapy from entering the clinic. ... 3850 Daltons, at least about 3900 Daltons, at least about 3950 ...

US6387371B1 - Monoclonal antibodies directed to the HER2 ...

https://patents.google.com/patent/US6387371B1/en
The immunochemical derivatives of the antibodies of this invention that are of prime ... Factor Receptor" Cancer Research 47:3847-3850 (1987). Tal et al., " ...

US6165464A - Monoclonal antibodies directed to the HER2 ...

https://patents.google.com/patent/US6165464A/en
The immunochemical derivatives of the antibodies of this invention that are of prime ... Factor Receptor Cancer Reserch 47:3847 3850 (1987). *. Tal et al., " ...

BE1014556A3 - Sequences nucleotidiques specifiques du genome ...

https://patents.google.com/patent/BE1014556A3/fr
... 3850 3404 CaRPl21A 3 Canh 6.2287 18238 18642 Rtbosomal protem, 3.Pfime ... 3 prime end no significant match orf6 5166 <Desc/Clms Page number 55> EMI55 ...

Intercontinental Exchange Reports Strong Full Year 2023 Results

https://news.google.com/__i/rss/rd/articles/CBMiOGh0dHBzOi8vd3d3LmJ1c2luZXNzd2lyZS5jb20vbmV3cy9ob21lLzIwMjQwMjA4MTM0NTI5L2Vu0gEA
Feb 8, 2024 ... ... factors affecting our financial condition and results of operations than GAAP measures alone. ... (NYSE: ICE), a leading global provider of ...

US7390483B2 - Universal GM-CSF expressing bystander human ...

https://patents.google.com/patent/US7390483B2/en
Levitsky et al., "Immunization with granulocyte-macrophage colony-stimulating factor-transduced, but no B7-1-transduced, lymphoma cells primes idiotype-specific ...

Nicolas Manel Lab - Publications

https://sites.google.com/view/nicolasmanellab/publications
A genome-wide CRISPR screen identifies regulation factors of the TLR3 signaling pathway. ... prime/727592526. - David Durantel, Inca Kusters, Jacques Louis, ...

WO2017077394A2 - Materials and methods for treatment of ...

https://patents.google.com/patent/WO2017077394A2/zh
Prime editing of the -115 region in the hbg1 and/or hbg2 promoter for ... 6, 2002, pages 3850 - 6. MA, H. ET AL., MOLECULAR THERAPY - NUCLEIC ACIDS, vol ...

WO2012115885A1 - Circulating biomarkers - Google Patents

https://patents.google.com/patent/WO2012115885A1/en20
... factor 8-associated microvesicles Endocrinol (2007) 148:3850-3862; Baj-Krzyworzeka et al. Tumour-derived microvesicles carry several surface determinants ...